Treating the Problem: Addressing Anticompetitive Conduct and Consolidation in Health Care Markets

Hearing

Date:

Thu, 04/29/2021 - 1:00 PM

Location:

2141 RHOB

Witnesses

Panel 1

The Honorable Amy Klobuchar

United States Senator, United States Senate

Senator Klobuchar Statement

The Honorable Chuck Grassley

United States Senator, United States Senate

Senator Grassley Statement

The Honorable Richard Blumenthal

United States Senator, United States Senate

Senator Blumenthal Statement

The Honorable John Cornyn

United States Senator, United States Senate

Senator Cornyn Statement

The Honorable Mike Lee

United States Senator, United States Senate

Senator Lee Statement

The Honorable Carolyn Maloney

Congresswoman, United States House of Representatives

Chairwoman Maloney Statement

Panel 2

Dr. Leemore Dafny

Bruce V. Rauner Professor of Business Administration,

Dr. Dafny Statement

Dr. Dafny Bio

Dr. Dafny Truth in Testimony

Mr. Michael Carrier

Distinguished Professor and Co-Director, Rutgers Institute for Policy and Law

Professor Carrier Statement

Professor Carrier Bio

Professor Carrier Truth in Testimony

Ms. Robin Feldman

Arthur J. Goldberg Distinguished Professor of Law, The University of California Hastings College of Law

Professor Feldman Statement

Professor Feldman Bio

Professor Feldman Truth in Testimony

Mr. Alden Abbott

Senior Research Fellow, George Mason Universitys Mercatus Center

Mr. Abbott Statement

Mr. Abbott Bio

Mr. Abbott Truth in Testimony

Meeting Documents

Hearing Notice

Statement for the record from Kristen McGovern, the Executive Director of the Partnership to Empower Physician Led Care submitted by the Honorable David N. Cicilline

Statement for the record from George Slover, Senior Policy Counsel, Consumer Reports submitted by the Honorable David N. Cicilline

Statement for the record from the Purchaser Business Group on Health submitted by the Honorable David N. Cicilline

Statement for the record from Marni Jameson Carey, Executive Director, Association of Independent Doctors submitted by the Honorable David N. Cicilline

Statement for the record from Patrick Kilbride, Global Innovation Policy Center submitted by the Honorable David N. Cicilline

Statement for the record from Christopher G. Sheeron, President, Action for Health submitted by the Honorable Jim Jordan

Professor Feldman's Response to The Honorable Eric Swalwell's Question for the Record

Subcommittees

Antitrust, Commercial, and Administrative Law (117th Congress)

Issues: Antitrust Patent and Trademark